Treace Medical Concepts Inc expected to post a loss of 14 cents a share - Earnings Preview

Treace Medical Concepts

27/02/2023 22:56

* Treace Medical Concepts Inc  TMCI.OQ   TMCI.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 1 (estimated). 
    * The Ponte Vedra Florida-based  company is expected to
report  a
32.8% increase in revenue to $44.4 million from $33.44 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. The company's guidance on January 9 2023, for
the period ended December 31, was for revenue between $49.10
million and $49.60 million.
    * ​Refinitiv's mean analyst estimate for Treace Medical
Concepts
Inc is for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $29.5​, above​ its last closing price of $21.89.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.29       -0.29      -0.22     Beat    23.5
 Jun. 30 2022  -0.19       -0.20      -0.31     Missed  -51.2
 Mar. 31 2022  -0.21       -0.20      -0.16     Beat    21​
 Dec. 31 2021  -0.01       0.00       -0.12     Missed  -2,300
 ​​Sep.        -0.12       -0.12      -0.12     Met     0
 30 2021                                                
 Jun. 30 2021  -0.12       -0.12      -0.10     Beat    16.7​
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7
 This summary was machine generated February 27 at 22:55 GMT. 
All figures in US dollars  unless otherwise stated